Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diarrhea × Cefixime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor 1 Relapsed Solid Tumors 1 Drug-Related Side Effects and Adverse Reactions 1 Diarrhea 1

Interventions

Irinotecan 3 Theophylline 1 Temozolomide 1 Oxaliplatin 1 Loperamide 1 Leucovorin 1 Fluorouracil 1 Fecal Microbiota Transplantation 1 Erlotinib Hydrochloride 1 Celecoxib 1 Cefpodoxime 1 Cefixime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00093353 2010-10-15

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Children's Hospital Los Angeles

Phase 1 Completed

Diarrhea, Neuroblastoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡